ÂÜÀòÂÒÂ×

Gabriella Galli's work experience begins in 1995 at Covance, where they held various roles including Executive Director Strategic Accounts from September 1995 to March 2011. Gabriella also served as Executive Director Strategic Development Clinical Operations from an unknown start date to an unknown end date in 2007, and as Executive Director Clinical Operations Europe from an unknown start date to an unknown end date in 2005.

In 2011, Galli joined Amgen as a Senior Manager, where they worked from September 2011 to June 2018. During their time at Amgen, they also briefly served as a Senior Manager Development Operations and Regional Clinical Trial Manager in September 2011.

Currently, Galli is working at T3 Pharmaceuticals AG as the Head of Clinical Operations. Gabriella started their role in June 2019, and as of now, there is no specified end date for this position.

Gabriella Galli earned their PhD in Molecular Biology from the University of Zurich from 1980 to 1983.